EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Rifampin-induced fluvastatin toxicity: a case report and review of literature

Ahmed Farghali iD, Hesham Mahmoud iD, Muhammad Salem iD

Oxford Medical Case Reports · 03.08.2026 · 2026 (8)

DOI: 10.1093/omcr/omag144 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oxford Medical Case Reports, online erschienen am 03.08.2026. Verfasst von Ahmed Farghali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Hamad General Hospital, P.O. box 3050, Doha, Qatar. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluvastatin is extensively metabolized by CYP2C9, which is induced by rifampin over several weeks, leading to a concentration decline. However, since rifampin is a potent inhibitor of the primary first-pass hepatic statin uptake transporter, the organic anion transporting polypeptide 1B1 (OATP1B1), simultaneous administration has been shown to significantly increase statin exposure. We report a previously fluvastatin-tolerant 63-year-old woman with nonalcoholic steatohepatitis who developed statin-induced rhabdomyolysis four weeks after the initiation and co-administration of rifampin for tuberculosis. After both medications were stopped, the patient showed clinical and biochemical improvement. While this report is the first to describe a clinical outcome of this interaction, multiple pharmacokinetic studies have demonstrated opposing, time-dependent rifampin effects on statin concentrations. Safe management of this challenging interaction includes statin dose reduction and/or separate administration upon rifampin initiation until the anticipated onset of CYP induction, followed by careful and gradual dose titration with monitoring of both effectiveness and toxicity.

Schlagwörter

Stichwörter der Autor:innen

CYP2C9FluvastatinOATP1B1drug interactionrhabdomyolysisrifampin

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Hamad General Hospital, P.O. box 3050, Doha, Qatar.

ORCID-Profile: Ahmed Farghali, Hesham Mahmoud, Muhammad Salem

Zitieren

APA

Farghali, A., Mahmoud, H., & Salem, M. (2026). Rifampin-induced fluvastatin toxicity: a case report and review of literature. Oxford Medical Case Reports, 2026(8). https://doi.org/10.1093/omcr/omag144

Vancouver

Farghali A, Mahmoud H, Salem M. Rifampin-induced fluvastatin toxicity: a case report and review of literature. Oxford Medical Case Reports. 2026;2026(8). doi:10.1093/omcr/omag144

BibTeX
@article{Farghali2026,
  author = {Farghali, Ahmed and Mahmoud, Hesham and Salem, Muhammad},
  title = {Rifampin-induced fluvastatin toxicity: a case report and review of literature},
  journal = {Oxford Medical Case Reports},
  year = {2026},
  volume = {2026},
  number = {8},
  doi = {10.1093/omcr/omag144}
}
Kostenlos starten →